ASTS
ASTS's valuation appears fair while fundamentals provide solid support and forward estimates point to narrowing losses and improving margins, though analyst coverage is limited and estimates vary widely.
ASTS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| EPS | -$2.16 | -$1.04 | $1.12 lower-$1.12 |
| FCF | -$1.6B | -$350.8M | -$1.3B-$1.3B |
| Loading historical comparisons… | |||
ASTS’s earnings are below their historical averages.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Loss narrowing |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
ASTS’s outlook is generally improving, though analyst coverage is limited.
ASTS PE Valuation
This table applies ASTS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
ASTS Earnings Per Share
This chart tracks ASTS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
ASTS Quarterly Revenue
This chart tracks ASTS's quarterly revenue over time and shows how sales are changing from year to year.
ASTS Free Cash Flow
This chart tracks ASTS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
ASTS Total Shares
This chart tracks changes in ASTS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
ASTS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
ASTS PE vs Technology Sector
This chart compares ASTS's price-to-earnings (PE) ratio with the Technology sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
ASTS Weekly Price
This chart uses ASTS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
ASTS Weekly Moving Averages
This chart compares ASTS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
ASTS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
MDA
MDA's valuation appears fair, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though analyst coverage is limited.
MDA vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 51x | 56x | 9% lower-9% |
| EPS | $0.57 | $0.34 | 69% higher+69% |
| FCF | -$107.4M | $118.4M | 191% lower-191% |
| Loading historical comparisons… | |||
MDA’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
MDA Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Deteriorating |
| Forward earnings | Decline |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
MDA’s outlook is mixed, with weaker expected earnings weighing on the picture.
MDA PE Valuation
This table applies MDA's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
MDA Earnings Per Share
This chart tracks MDA's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
MDA Quarterly Revenue
This chart tracks MDA's quarterly revenue over time and shows how sales are changing from year to year.
MDA Free Cash Flow
This chart tracks MDA's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
MDA Total Shares
This chart tracks changes in MDA's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
MDA Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
MDA PE vs Technology Sector
This chart compares MDA's price-to-earnings (PE) ratio with the Technology sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
MDA Weekly Price
This chart uses MDA's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
MDA Weekly Moving Averages
This chart compares MDA's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
MDA Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.